Karan Goel - Publications

Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: June 22, 2026

Nootkatone as a multi-target modulator of the PD-L1/PD-1 signaling in pancreatic cancer: network pharmacology, docking, molecular dynamics, and DFT analysis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 31, 2026

Imatinib: A Multifunctional Tyrosine Kinase Inhibitor with Diverse Mechanisms Targeting BCR-ABL, c-KIT, and PDGFR in Cancer Therapy.

Journal: Current pharmaceutical design

Published: March 06, 2026

Molecular modelling-driven formulation design for targeted pulmonary drug delivery.

Journal: International journal of pharmaceutics

Published: March 01, 2026

Dual Disruption: Targeting Mitotic Processes and Epigenetic Regulation to Overcome Anticancer Drug Resistance.

Journal: Current pharmaceutical design

Published: August 21, 2025

New insights on pharmacological potential of montelukast: a comprehensive review.

Journal: Inflammopharmacology

Published: June 13, 2025

Progress in modifying and delivering mRNA therapies for cancer immunotherapy.

Journal: Advances in immunology

Published: May 31, 2025

Plasmid DNA and mRNA delivery: Approaches and challenges.

Journal: Advances in immunology

Published: May 31, 2025

Understanding and Mitigating Cardiotoxicity in Anticancer Drug Therapy: A Comprehensive Review.

Journal: Current drug safety

Published: October 20, 2024

Relationship between Pituitary Gland and Stem Cell in the Aspect of Hormone Production and Disease Prevention: A Narrative Review.

Journal: Endocrine, metabolic & immune disorders drug targets

Published: May 06, 2024